Global Vascular Stents Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

According to the CDC, approximately 69,700 people died from heart disease, which is 1 in every 5 deaths in the United States, in 2021

The Global Vascular Stents Market is estimated to be USD 18.54 Bn in 2023 and is expected to reach USD 27.13 Bn by 2028 growing at a CAGR of 7.91%.

A vascular stent is a small device that is used to clear and prevent blockages in the heart valves and arteries. Common materials used to make these stents include metals like stainless steel, nitinol (a nickel-titanium alloy), and cobalt-chromium. It is utilized to give stenotic or blocked blood arteries internal structural support. Vascular stenting is the procedure of inserting a vascular stent within the body. These can range from expandable metal meshes used during percutaneous vascular treatments to tubular stent grafts used to treat aneurysms. The stent is expanded using a balloon or a self-expanding device once it has been positioned in the desired spot. The use of vascular stents in the treatment of atherosclerosis, or the hardening and constriction of arteries because of plaque buildup, has revolutionized the field. They are frequently employed in the management of carotid artery disease, peripheral arterial disease, and coronary artery disease. They are also employed for non-vascular purposes, like in the biliary tree to clear bile duct blockages.

The market is driven by an increase in the demand for minimally invasive surgical treatments as well as a growing worldwide geriatric population. The prevalence of cardiovascular illnesses rises as the population ages, increasing the need for stent installation treatments. Little incisions are used during the procedure, which may lead to less pain and a quicker recovery than open surgery. Lowering the risk of heart attack, stroke, or other consequences linked to clogged blood arteries, improves patient outcomes. The clogging or blocking of blood arteries is facilitated by smoking, alcohol consumption, and the consumption of unhealthful foods. Moreover, there has been an increase in the prevalence of several diseases, including ischemic heart disease, aortic aneurysm, and peripheral artery disease (PAD).

However, the market is restrained by the availability of alternative treatment methods for vascular disease. The patient's exact illness and other personal elements, like age, general health, and medical history, will influence the therapeutic approach used. Several times, invasive procedures can be avoided by making lifestyle modifications like exercising, eating a balanced diet, and quitting smoking. Medications such as antiplatelet drugs, blood thinners, or cholesterol-lowering drugs may be provided depending on the kind and degree of the blockage to assist treat the illness. Like vascular stenting, angioplasty is a minimally invasive technique that includes opening the blocked blood vessel with a balloon catheter. Sometimes open-heart surgery may be required, especially when the obstruction is severe or involves many blood vessels. Thrombolysis may be performed to dissolve blood clots that are the source of blockages to improve blood flow.

However, the market has an opportunity in increasing R&D Investments in the Biotechnology and Pharmaceutical Industries as new materials, like polymers and biocompatible metals, can be employed in stent design to enhance functionality and lower the risk of problems as a result of advancements in materials science. The materials used to make today's stents are durable and may eventually result in issues like restenosis or thrombosis. The bioresorbable stents, on the other hand, are made to break down naturally over time, possibly lowering the risk of problems and enhancing long-term results. To lower the danger of restenosis and increase the stent's long-term effectiveness, drug-eluting stents are made to release medication directly into the blood vessel.

• The development of stents customized to a patient's unique genetic profile or disease condition may be made possible by advances in genomics and personalized medicine, potentially increasing treatment efficacy and lowering the risk of consequences. The market is expanding because of the new trend of peripheral and endovascular aneurysm repair (EVAR) stent grafting.
• However, the market is challenged by the complication associated with stent implantation and the stringent regulations imposed by the government to ensure patient safety. Restenosis, thrombosis, in-stent restenosis, stent fracture, migration, and allergic responses are a few possible side effects of stent placement that may result in symptoms like redness, itching, or breathing difficulties. Rarely, the stent may puncture a blood vessel, which could result in bleeding or other issues. The pricey nature of the process itself will further impede the market's growth rate.

Market Segmentations

• The Global Vascular Stents Market is segmented based on Type, Product, Material, Mode of Delivery, End-User, and Geography.
• By Type, the market is classified into Drug-Eluting Stents, Bare-Metal Stents, and Bio Absorbable Stents.
• Drug-Eluting Stents (DES) segment dominates the market. Strengthening DES's position as the standard device for PCI operations depends in large part on the ongoing development and introduction of new devices. To treat coronary artery disease, this kind of stent is employed. They resemble conventional balloon-expandable stents in terms of design, but they are coated with a specific drug that is delivered gradually over time. For individuals with coronary artery disease, the use of drug-eluting stents has been demonstrated to be successful in lowering the risk of restenosis and enhancing long-term outcomes. The market's rivals continue to create and introduce technologically sophisticated DES, with significant debuts including XIENCE Skypoint by Abbott Laboratories, Resolute Onyx by Medtronic, and Synergy by Boston Scientific. These more recent DES offer superior stent integrity, higher deliverability, and fewer complication rates as compared to older devices.
• By Product, the market is classified into Coronary Stents, Peripheral Vascular Stents, and Evar Stent Grafts.
• The coronary stents segment has the biggest market share. The demand for the coronary stents market is rising as a result of the increased prevalence of coronary artery disease and technological advancements in coronary stents. An important factor contributing to the increasing demand for coronary stents on the global market is the rising investments made by emerging firms in coronary stent research and development to produce unique and advanced coronary stents such as bioengineered stents, bioresorbable stents, and so on.
• By Material, the market is classified into Metallic Stents and Others.
• Metallic stents currently have the largest revenue share in the vascular stent market. They are frequently employed in the treatment of cardiovascular disease and are normally constructed of stainless steel, cobalt chromium, or nitinol. The great radial strength of metallic stents, which enables them to apply tremendous force on the blood artery and maintain it open, is one factor in their popularity. Metallic stents are also reasonably simple to make and have a track record of safety and effectiveness. However, bioresorbable stents, which are intended to disappear over time and possibly lower the risk of long-term problems such as restenosis or thrombosis, are also gaining popularity. While bioresorbable stents currently have a smaller market share than metallic stents, as more research is conducted and more information about their safety and efficacy becomes available, market share is anticipated to increase in the upcoming years. Bioresorbable stents are typically made of materials like polymers or magnesium.
• By Mode of Delivery, the market is classified into Balloon-Expandable Stents and Self-Expanding Stents.
• The Balloon-Expandable Stents segment shares the largest revenue share. These metal stents are intended to be permanently inserted in the damaged blood artery. A thin, flexible catheter is used to place the stent into the vessel's constricted region. These stents are also utilized in other areas of the body, such as the neck and legs, where blood arteries may narrow or get clogged. Yet, they are generally secure and efficient. Balloon-expandable stents' main advantage is that they increase blood flow to the injured area. It aids in the reduction or elimination of symptoms like leg discomfort, shortness of breath, and chest pain. It has a quicker recovery, minimizes the risk of complications, and produces benefits that last. These advantages of balloon-expandable will positively affect the market expansion.
• By End-User, the market is classified into Hospitals & Cardiac Centers, and Ambulatory Surgical Centers.
• The growing use of stents in hospital and clinic environments shares the largest revenue. Hospitals have a lot of stents since they are important medical devices that are frequently used in a range of minimally invasive and surgical procedures. A growth in disease populations is a result of changes in lifestyle, the adoption of unhealthy behaviors like drinking alcohol and smoking, as well as environmental problems like pollution. A spike in hospital admissions would therefore feed the need for creative treatment options, opening a wealth of potential prospects for the sector. Also, the effectiveness of post-operative treatments and the accessibility of trained healthcare professionals will support category expansion.
• By Geography, the market is classified into the Americas, Europe, Middle East & Africa, and Asia-Pacific.
• North America has dominated the market and will continue to do so during the forecast period due to the rapid increase in the adoption of minimal or non-invasive surgical procedures. Also, this region's market share in the worldwide vascular stent market is being driven by the quickening pace of technological advancement. The region's rising elderly population, which requires healthcare, is the main growth engine. Clinical trials for novel stents are still being conducted in the United States, and regulatory agencies have given their permission. Vascular stents are produced by several top medical device companies in North America, including Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson. These businesses provide a wide selection of stents made to cater to the requirements of various patients and medical situations. Vascular stents are one type of medical device that is governed by Health Canada in Canada.

Recent Development

• Cordis announced that the FDA has authorized the S.M.A.R.T. RADIANZTM Vascular Stent System, a self-expanding stent designed specifically for radial peripheral procedures. The S.M.A.R.T. RADIANZTM Vascular Stent System allows for accurate and efficient stent implantation inside the superficial femoral (SFA) and iliac arteries. - March 2022
• Translumina announced the availability of VIVO ISAR, its next-generation dual drug polymer-free coated stent (DDCS), in several international countries, including Europe. - April 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, AngioDynamics, B. Braun Melsungen, Biosensors International Group, Biotronik Se & Co. Kg, etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Ireland, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
• The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Vascular Stents Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Vascular Stents Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Vascular Stents Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market